New online tool aims to ease breast cancer symptoms for young women
NCT ID NCT04379414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a web-based portal (YES) for women aged 18–39 newly diagnosed with breast cancer. The portal helps track symptoms, offers self-management tips, and connects users with peers. Researchers want to see if it reduces issues like vaginal dryness and improves well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
YES portal (web-based behavioral intervention)
What this could lead to
If successful, this portal could provide a scalable way to improve symptom management and quality of life for young breast cancer patients.
What could go wrong
This is a behavioral intervention, not a drug; benefits may be modest. The trial is still recruiting and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States